A 38-year-old woman with PCOS presents with dark, velvety patches on her neck and axillae. Clinical examination confirms acanthosis nigricans. She has irregular menses and hirsutism. Her fasting glucose is 98 mg/dL and HbA1c is 5.8%. Which investigation is most appropriate to further characterize her metabolic status and guide management?

## Investigation of Choice for Metabolic Characterization in AN with PCOS ### Clinical Scenario Analysis This patient has: - Acanthosis nigricans (cutaneous marker of insulin resistance) - PCOS (strong association with insulin resistance) - Borderline fasting glucose (98 mg/dL) - Normal HbA1c (5.8%) - Normal fasting glucose does NOT exclude impaired glucose tolerance **Key Point:** In PCOS with AN, the fasting glucose may be falsely reassuring. Many patients have normal fasting glucose but impaired glucose tolerance (IGT) or early-stage diabetes detectable only on dynamic testing. ### Why OGTT is the Investigation of Choice | Aspect | OGTT | Fasting Glucose | |---|---|---| | **Sensitivity for IGT** | High (detects 2-hour glucose elevation) | Low (misses IGT) | | **Clinical utility in PCOS** | Gold standard for glucose tolerance assessment | Insufficient alone | | **Prognostic value** | Identifies progression risk | Limited | | **Guidelines recommendation** | Recommended in all PCOS patients | Insufficient screening | **High-Yield:** OGTT is the gold standard for diagnosing impaired fasting glucose (IFG), impaired glucose tolerance (IGT), and type 2 diabetes mellitus. In PCOS, 30–40% of patients have IGT despite normal fasting glucose. **Clinical Pearl:** The 2-hour post-load glucose value in OGTT is more predictive of cardiovascular risk and progression to diabetes than fasting glucose alone, especially in insulin-resistant states like PCOS. ### Diagnostic Criteria Using OGTT ```mermaid flowchart TD A[OGTT Results]:::outcome --> B{2-hour glucose level?}:::decision B -->|< 140 mg/dL| C[Normal glucose tolerance]:::outcome B -->|140-199 mg/dL| D[Impaired glucose tolerance]:::outcome B -->|≥ 200 mg/dL| E[Type 2 Diabetes Mellitus]:::outcome C --> F[Lifestyle modification + monitoring]:::action D --> G[Intensive lifestyle intervention + metformin]:::action E --> H[Antidiabetic therapy]:::action ``` **Mnemonic: OGTT in PCOS** — **O**ral glucose tolerance test, **G**old standard for glucose assessment, **T**wo-hour value is key, **T**ype 2 diabetes detection, **I**mpaired tolerance identification, **P**rogression risk stratification, **C**ardiovascular risk assessment, **O**ptimal management guidance, **S**creening in all patients.